Congress Materials

Medical Information
Saudi Arabia
 

This medical Information website is intended only for Healthcare Professionals in the Kingdom of Saudi Arabia. This information is not intended as medical advice. Responsibility for patient care resides with the healthcare professional on the basis of his or her professional license, experience and knowledge of the patient.

Please choose the category that best describes you.

This content is intended for Healthcare professionals in Saudi Arabia. Would you like to proceed?

I am a healthcare professional registered to practice in KSAYes, I am a healthcare professional registered to practice in KSA
SelectI am a healthcare professional registered to practice in KSAYes, I am a healthcare professional registered to practice in KSA
I am not a healthcare professionalNo, go back to the patient portal
SelectI am not a healthcare professionalNo, go back to the patient portal
Non-Saudi Arabia residents click here.
The information on this page pertains to select congresses, congress materials, therapeutic and disease areas. It is not intended to serve as a comprehensive overview of all congresses, congress materials, therapeutic and disease areas.
Poster
Fleischmann R, Haraoui B, Buch MH, Gold D, Sawyerr G, Shi H, Diehl A, Lee K June 6, 2021 EULAR 2021 Rheumatoid Arthritis

Analysis of disease activity measures in the context of a methotrexate withdrawal study among patients with rheumatoid arthritis treated with tofacitinib 11 mg once daily + methotrexate: Post hoc analysis of data from ORAL Shift

View Presentation
Poster
Cohen SB, Chen Y-H, Sugiyama N, Rivas JL, Diehl A, Lukic T, Paulissen J, Fan H, Hirose T, Keystone E June 6, 2021 EULAR 2021 Rheumatoid Arthritis

Clinical and functional response to tofacitinib in patients with rheumatoid arthritis: Probability plot analysis of results from a 48-week Phase 3b/4 methotrexate withdrawal study

View Presentation
Poster
Navarro-Compán V, Wei JC-C, Van den Bosch F, Magrey M, Wang L, Fleishaker D, Cappelleri JC, Wang C, Wu J, Dina O, Fallon L, Strand V June 6, 2021 EULAR 2021 Ankylosing Spondylitis

Effect of tofacitinib on patient-reported outcomes in patients with active ankylosing spondylitis: Results from a Phase 3 trial

View Presentation
Poster
Orbai A-M, Mease PJ, Helliwell P, FitzGerald O, Bedaiwi M, Fleishaker D, Mundayat R, Young P June 6, 2021 EULAR 2021 Psoriatic Arthritis

Efficacy of tofacitinib on dactylitis in individual digits in patients with active psoriatic arthritis

View Presentation
Poster
Conaghan PG, Østergaard M, Troum O, Xie Z, Brett A, Snyder M, Ebrahim A, Chapman D, Sawyer G, Andrews J June 6, 2021 EULAR 2021 Rheumatoid Arthritis

Exploring novel tenosynovitis and combined inflammation imaging outcomes: results from a randomised controlled trial in early rheumatoid arthritis

View Presentation
Poster
Matsui T, Sugiyama N, Toyoizumi S, Matsuyama F, Murata T, Urata Y, Kawahata K, Tohma S June 6, 2021 EULAR 2021 Rheumatoid Arthritis

Incidence of malignancies in Japanese patients with rheumatoid arthritis: Data from a large Japanese national registry

View Presentation
Oral Presentation
Harigai M, Sugitani N, Sakai R, Inoue E, Mochizuki M, Toyoizumi S, Yoshii N, Sugiyama N, Tanaka E, Yamanaka H June 6, 2021 EULAR 2021 Rheumatoid Arthritis

Incidence of malignancy in Japanese patients with rheumatoid arthritis: Data from the Japanese IORRA patient registry

View Presentation
Poster
Yamaoka K, Cohen SB, Sugiyama N, Shi H, Rivas JL, Diehl A, Smolen JS June 6, 2021 EULAR 2021 Rheumatoid Arthritis

Predictors of durable clinical response to tofacitinib 11 mg once daily with or without methotrexate in patients with rheumatoid arthritis: Post hoc analysis of data from a Phase 3b/4 methotrexate withdrawal study

View Presentation
Oral Presentation
Cella D, Lenderking W, Chongpinitchai P, Bushmakin AG, Dina O, Wang L, Cappelleri JC, Navarro-Compán V June 6, 2021 EULAR 2021 Ankylosing Spondylitis

Psychometric evaluation of Functional Assessment of Chronic Illness Therapy-Fatigue in patients with active ankylosing spondylitis

View Presentation
Poster
Charles-Schoeman C, Hyde C, Guan S, Parikh N, Wang J, Shahbazian A, Stockert L, Andrews J June 6, 2021 EULAR 2021 Rheumatoid Arthritis

Relationship between paraoxonase-1 genotype, activity and major adverse cardiovascular events in patients with rheumatoid arthritis receiving tofacitinib

View Presentation